Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis

The ecosystem of the gut microbiota consists of diverse intestinal species with multiple metabolic and immunologic activities and it is closely connected with the intestinal epithelia and mucosal immune response, with which it builds a complex barrier against intestinal pathogenic bacteria. The micr...

Full description

Bibliographic Details
Main Authors: Simona Iacob, Diana Gabriela Iacob
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-08-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2019.01676/full
_version_ 1818278642497617920
author Simona Iacob
Simona Iacob
Diana Gabriela Iacob
author_facet Simona Iacob
Simona Iacob
Diana Gabriela Iacob
author_sort Simona Iacob
collection DOAJ
description The ecosystem of the gut microbiota consists of diverse intestinal species with multiple metabolic and immunologic activities and it is closely connected with the intestinal epithelia and mucosal immune response, with which it builds a complex barrier against intestinal pathogenic bacteria. The microbiota ensures the integrity of the gut barrier through multiple mechanisms, either by releasing antibacterial molecules (bacteriocins) and anti-inflammatory short-chain fatty acids or by activating essential cell receptors for the immune response. Experimental studies have confirmed the role of the intestinal microbiota in the epigenetic modulation of the gut barrier through posttranslational histone modifications and regulatory mechanisms induced by epithelial miRNA in the epithelial lumen. Any quantitative or functional changes of the intestinal microbiota, referred to as dysbiosis, alter the immune response, decrease epithelial permeability and destabilize intestinal homeostasis. Consequently, the overgrowth of pathobionts (Staphylococcus, Pseudomonas, and Escherichia coli) favors intestinal translocations with Gram negative bacteria or their endotoxins and could trigger sepsis, septic shock, secondary peritonitis, or various intestinal infections. Intestinal infections also induce epithelial lesions and perpetuate the risk of bacterial translocation and dysbiosis through epithelial ischemia and pro-inflammatory cytokines. Furthermore, the decline of protective anaerobic bacteria (Bifidobacterium and Lactobacillus) and inadequate release of immune modulators (such as butyrate) affects the release of antimicrobial peptides, de-represses microbial virulence factors and alters the innate immune response. As a result, intestinal germs modulate liver pathology and represent a common etiology of infections in HIV immunosuppressed patients. Antibiotic and antiretroviral treatments also promote intestinal dysbiosis, followed by the selection of resistant germs which could later become a source of infections. The current article addresses the strong correlations between the intestinal barrier and the microbiota and discusses the role of dysbiosis in destabilizing the intestinal barrier and promoting infectious diseases.
first_indexed 2024-12-12T23:20:41Z
format Article
id doaj.art-21b7a5b1fca44a39bd4e9b4289f3a780
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-12T23:20:41Z
publishDate 2019-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-21b7a5b1fca44a39bd4e9b4289f3a7802022-12-22T00:08:17ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2019-08-011010.3389/fmicb.2019.01676448283Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: DysbiosisSimona Iacob0Simona Iacob1Diana Gabriela Iacob2Infectious Diseases Department, “Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaNational Institute of Infectious Diseases “Prof. Dr. Matei Balş”, Bucharest, RomaniaInfectious Diseases Department, “Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaThe ecosystem of the gut microbiota consists of diverse intestinal species with multiple metabolic and immunologic activities and it is closely connected with the intestinal epithelia and mucosal immune response, with which it builds a complex barrier against intestinal pathogenic bacteria. The microbiota ensures the integrity of the gut barrier through multiple mechanisms, either by releasing antibacterial molecules (bacteriocins) and anti-inflammatory short-chain fatty acids or by activating essential cell receptors for the immune response. Experimental studies have confirmed the role of the intestinal microbiota in the epigenetic modulation of the gut barrier through posttranslational histone modifications and regulatory mechanisms induced by epithelial miRNA in the epithelial lumen. Any quantitative or functional changes of the intestinal microbiota, referred to as dysbiosis, alter the immune response, decrease epithelial permeability and destabilize intestinal homeostasis. Consequently, the overgrowth of pathobionts (Staphylococcus, Pseudomonas, and Escherichia coli) favors intestinal translocations with Gram negative bacteria or their endotoxins and could trigger sepsis, septic shock, secondary peritonitis, or various intestinal infections. Intestinal infections also induce epithelial lesions and perpetuate the risk of bacterial translocation and dysbiosis through epithelial ischemia and pro-inflammatory cytokines. Furthermore, the decline of protective anaerobic bacteria (Bifidobacterium and Lactobacillus) and inadequate release of immune modulators (such as butyrate) affects the release of antimicrobial peptides, de-represses microbial virulence factors and alters the innate immune response. As a result, intestinal germs modulate liver pathology and represent a common etiology of infections in HIV immunosuppressed patients. Antibiotic and antiretroviral treatments also promote intestinal dysbiosis, followed by the selection of resistant germs which could later become a source of infections. The current article addresses the strong correlations between the intestinal barrier and the microbiota and discusses the role of dysbiosis in destabilizing the intestinal barrier and promoting infectious diseases.https://www.frontiersin.org/article/10.3389/fmicb.2019.01676/fulldysbiosisintestinal microbiotaepigenetic modulationshort chain fatty acidsimmunitysepsis
spellingShingle Simona Iacob
Simona Iacob
Diana Gabriela Iacob
Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
Frontiers in Microbiology
dysbiosis
intestinal microbiota
epigenetic modulation
short chain fatty acids
immunity
sepsis
title Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
title_full Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
title_fullStr Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
title_full_unstemmed Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
title_short Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
title_sort infectious threats the intestinal barrier and its trojan horse dysbiosis
topic dysbiosis
intestinal microbiota
epigenetic modulation
short chain fatty acids
immunity
sepsis
url https://www.frontiersin.org/article/10.3389/fmicb.2019.01676/full
work_keys_str_mv AT simonaiacob infectiousthreatstheintestinalbarrieranditstrojanhorsedysbiosis
AT simonaiacob infectiousthreatstheintestinalbarrieranditstrojanhorsedysbiosis
AT dianagabrielaiacob infectiousthreatstheintestinalbarrieranditstrojanhorsedysbiosis